Search research articles
Contact Us
Filters
Showing results (41-50 of 516) with videos related to
Page
of 52
Sort By:
European Urology Focus
|
July 21, 2017
Against the Role of Inflammatory Markers in Renal Cell Carcinoma Prognosis: The Missing Link Between Evidence of Association and Clinical Applicability
Alessandro Larcher, Paolo Dell'Oglio, Andrea Salonia, et al.
European Urology
|
February 11, 2017
Partial Nephrectomy for Large or Complex Masses: Option or Obsolete?
Ithaar H Derweesh, Riccardo Autorino, Karim Bensalah, et al.
European Urology
|
May 20, 2008
Clinicians are most familiar with nomograms and rate their clinical usefulness highest, look-up tables are second best
Umberto Capitanio, Claudio Jeldres, Shahrokh F Shariat, et al.
The Lancet. Oncology
|
January 5, 2025
Molecular imaging targeting carbonic anhydrase 9 in clear-cell renal cell carcinoma: more than meets the eye
Alessandro Larcher, Fabrizia Gelardi, Francesco Montorsi, et al.
European Urology Focus
|
December 3, 2025
Re: Alessandro Parente, Kevin Verhoeff, Yanbo Wang, et al. Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma: An International Multicenter Study: Considerations for Further Research. Eur Urol Focus 2025;11:118-25
Ciro Piccolo, Alessandro Larcher, Francesco Cei, et al.
European Urology
|
May 9, 2016
Reply from Authors re: Steven C. Campbell, Wen Dong, Joe Zabell, Diego Aguilar Palacios. End-stage Renal Disease After Renal Surgery: Partial Nephrectomy Is Protective, but to What Degree and Consequence? Eur Urol 2016;70:562-3: Functional Outcomes After Renal Surgery: It's Time to Change Our Point of View
Umberto Capitanio, Alessandro Larcher, Paolo Dell'Oglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2022
Predicting the Risk of Progression in Patients With Kidney Cancer: Aiming at the Optimal Tool in the Optimal Setting
Umberto Capitanio, Giuseppe Rosiello, Andrea Necchi, et al.
BJU International
|
November 8, 2008
Can nomograms be superior to other prediction tools?
Shahrokh F Shariat, Umberto Capitanio, Claudio Jeldres, et al.
European Urology
|
April 3, 2024
Reply to Angela Estevez, Phillip Kim, Peter Chang, and Andrew A. Wagner's Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of <sup>99m</sup>Tc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol 2024;85:63-71
Giuseppe Basile, Alessandro Larcher, Arturo Chiti, et al.
European Urology
|
December 13, 2023
Reply to Giovanni Lughezzani, Paolo Casale, and Laura Evangelista's Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of <sup>99m</sup>Tc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol. 2024;85:63-71
Giuseppe Basile, Andrea Gallioli, Arturo Chiti, et al.
Page
of 52
Search research articles
Search
Showing results (41-50 of 516) with videos related to
Sort By:
Page
of 52
European Urology Focus
|
July 21, 2017
Against the Role of Inflammatory Markers in Renal Cell Carcinoma Prognosis: The Missing Link Between Evidence of Association and Clinical Applicability
Alessandro Larcher, Paolo Dell'Oglio, Andrea Salonia, et al.
European Urology
|
February 11, 2017
Partial Nephrectomy for Large or Complex Masses: Option or Obsolete?
Ithaar H Derweesh, Riccardo Autorino, Karim Bensalah, et al.
European Urology
|
May 20, 2008
Clinicians are most familiar with nomograms and rate their clinical usefulness highest, look-up tables are second best
Umberto Capitanio, Claudio Jeldres, Shahrokh F Shariat, et al.
The Lancet. Oncology
|
January 5, 2025
Molecular imaging targeting carbonic anhydrase 9 in clear-cell renal cell carcinoma: more than meets the eye
Alessandro Larcher, Fabrizia Gelardi, Francesco Montorsi, et al.
European Urology Focus
|
December 3, 2025
Re: Alessandro Parente, Kevin Verhoeff, Yanbo Wang, et al. Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma: An International Multicenter Study: Considerations for Further Research. Eur Urol Focus 2025;11:118-25
Ciro Piccolo, Alessandro Larcher, Francesco Cei, et al.
European Urology
|
May 9, 2016
Reply from Authors re: Steven C. Campbell, Wen Dong, Joe Zabell, Diego Aguilar Palacios. End-stage Renal Disease After Renal Surgery: Partial Nephrectomy Is Protective, but to What Degree and Consequence? Eur Urol 2016;70:562-3: Functional Outcomes After Renal Surgery: It's Time to Change Our Point of View
Umberto Capitanio, Alessandro Larcher, Paolo Dell'Oglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2022
Predicting the Risk of Progression in Patients With Kidney Cancer: Aiming at the Optimal Tool in the Optimal Setting
Umberto Capitanio, Giuseppe Rosiello, Andrea Necchi, et al.
BJU International
|
November 8, 2008
Can nomograms be superior to other prediction tools?
Shahrokh F Shariat, Umberto Capitanio, Claudio Jeldres, et al.
European Urology
|
April 3, 2024
Reply to Angela Estevez, Phillip Kim, Peter Chang, and Andrew A. Wagner's Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of <sup>99m</sup>Tc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol 2024;85:63-71
Giuseppe Basile, Alessandro Larcher, Arturo Chiti, et al.
European Urology
|
December 13, 2023
Reply to Giovanni Lughezzani, Paolo Casale, and Laura Evangelista's Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of <sup>99m</sup>Tc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol. 2024;85:63-71
Giuseppe Basile, Andrea Gallioli, Arturo Chiti, et al.
Page
of 52